Lowe’s Companies (NYSE: LOW) remains one of the most closely watched benchmarks in the home improvement and furnishing retail sector heading into mid-2026. The home improvement retail industry has faced significant headwinds
IP Group has attracted fresh scrutiny from value-focused investors, with the intellectual property commercialisation firm flagged as among the cheapest stocks on the FTSE 250. The London-listed company, which trades under the
More
PharmaEssentia has secured a significant regulatory milestone as the FDA approved a label expansion for its rare blood cancer drug Besremi, known generically as ropeginterferon alfa-2b-njft. The drug, first approved by the
More
Federal contractors selling innovative technology to the US government have an alternative procurement route available through a mechanism known as a Commercial Solutions Opening, or CSO. CSOs are designed to give agencies,
More
Family law programs remain among the most vital offerings at law schools across the United States, equipping students with skills to handle deeply personal and complex legal matters. Students in these programs
More
As artificial intelligence sentiment surges back to prominence, UK-listed stocks are quietly being left behind by the global flow of capital. New data from Bank of America signals a dramatic shift in
More
The FTSE 250 index serves as the primary breeding ground for future FTSE 100 constituents, with promotion and relegation reshuffles occurring quarterly. Index changes are determined by market capitalisation, meaning companies must
More
Andy Burnham’s political rise to Prime Minister has placed renewed focus on buying British across defence procurement, with British money spent on British firms. During a visit to a BAE Systems shipyard
More
New York Attorney General Wins $400,000 Settlement Against Online Medication Provider Thirty Madison
New York Attorney General Letitia James announced on 24 August 2026 that her office secured $400,000 from Thirty Madison, Inc. over allegations of consumer deception. The online medication provider allegedly misled customers
More
Troutman Pepper is facing a lawsuit from a former associate who alleges the firm dramatically changed its partnership criteria following a serious cardiac event. The associate’s legal claim combines allegations under the
More
Legal & General (LSE: LGEN) shares have climbed 19.5% over the past 12 months, finally showing some momentum after a prolonged period of underwhelming performance. The FTSE 100 insurer and asset manager
More